Reduced activity of DNA polymerase prepared from bleomycin-treated cancer cells.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D002247:Carbon Isotopes; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000378:metabolism; D046508:Culture Techniques; D003597:Cytosine Nucleotides / Q000378:metabolism; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D003864:Depression, Chemical; D005260:Female; D008113:Liver Neoplasms; D009374:Neoplasms, Experimental / Q000201:enzymology* / Q000378:metabolism; D010770:Phosphotransferases / Q000378:metabolism; D012316:RNA Nucleotidyltransferases / Q000378:metabolism; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D002247:Carbon Isotopes; D003597:Cytosine Nucleotides; D014316:Tritium; D001761:Bleomycin; D010770:Phosphotransferases; D004254:DNA Nucleotidyltransferases; D012316:RNA Nucleotidyltransferases; D013936:Thymidine